Given that the GSK‐3β activity can be regulated by ApoE in vitro,13, 14 we hypothesize that the activation of GSK‐3β may play a mediative role between ApoE ε4 and cognitive impairment in T2DM patients. The gene discussed is GSK3B; the disease is Cognitive impairment.